Skip to main content

Dyadic International Inc

DYAI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001213809

In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Dyadic International Inc changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of DYAI: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders39135−3
Shares4.68M249.2K4.78M+345.9K (+7.8%)
Value$6.93M$368.8K$4.98M−$1.59M (−24.2%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Dyadic International Inc at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to DYAI in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.255,800$266.0K0.00%
XTX Topco Ltd13,252$13.8K0.00%
Advisor Group Holdings, Inc.1,000$1.04K0.00%

Sold out (6)

Institutions that held Dyadic International Inc at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of DYAI in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Wolverine Trading, LLC13,647$20.2K
UBS Group AG9,764$14.5K
Riggs Asset Managment Co. Inc.1,000$1.48K
Royal Bank of Canada363$1.00K
Citigroup Inc187$277
Simplex Trading, LLC37$0

Not filed for Q3 2024 yet (1)

Institutions that held Dyadic International Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DYAI in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.249,185$368.8K